NEO
Price
$7.99
Change
+$0.01 (+0.13%)
Updated
Sep 8, 01:16 PM (EDT)
Capitalization
1.03B
64 days until earnings call
TWST
Price
$25.80
Change
+$0.04 (+0.16%)
Updated
Sep 8, 01:35 PM (EDT)
Capitalization
1.55B
77 days until earnings call
Interact to see
Advertisement

NEO vs TWST

Header iconNEO vs TWST Comparison
Open Charts NEO vs TWSTBanner chart's image
NeoGenomics
Price$7.99
Change+$0.01 (+0.13%)
Volume$347
Capitalization1.03B
Twist Bioscience
Price$25.80
Change+$0.04 (+0.16%)
Volume$601
Capitalization1.55B
NEO vs TWST Comparison Chart in %
Loading...
NEO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TWST
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
NEO vs. TWST commentary
Sep 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NEO is a Buy and TWST is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 08, 2025
Stock price -- (NEO: $7.98 vs. TWST: $25.76)
Brand notoriety: NEO and TWST are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: NEO: 139% vs. TWST: 89%
Market capitalization -- NEO: $1.03B vs. TWST: $1.55B
NEO [@Medical Specialties] is valued at $1.03B. TWST’s [@Medical Specialties] market capitalization is $1.55B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $10.69B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NEO’s FA Score shows that 0 FA rating(s) are green whileTWST’s FA Score has 0 green FA rating(s).

  • NEO’s FA Score: 0 green, 5 red.
  • TWST’s FA Score: 0 green, 5 red.
According to our system of comparison, NEO is a better buy in the long-term than TWST.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NEO’s TA Score shows that 6 TA indicator(s) are bullish while TWST’s TA Score has 5 bullish TA indicator(s).

  • NEO’s TA Score: 6 bullish, 4 bearish.
  • TWST’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, NEO is a better buy in the short-term than TWST.

Price Growth

NEO (@Medical Specialties) experienced а -9.11% price change this week, while TWST (@Medical Specialties) price change was -4.49% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +0.99%. For the same industry, the average monthly price growth was +8.35%, and the average quarterly price growth was +17.77%.

Reported Earning Dates

NEO is expected to report earnings on Nov 11, 2025.

TWST is expected to report earnings on Nov 24, 2025.

Industries' Descriptions

@Medical Specialties (+0.99% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TWST($1.56B) has a higher market cap than NEO($1.03B). TWST YTD gains are higher at: -44.566 vs. NEO (-51.578). NEO has higher annual earnings (EBITDA): -28.47M vs. TWST (-149.1M). TWST has more cash in the bank: 251M vs. NEO (164M). TWST has less debt than NEO: TWST (78.2M) vs NEO (412M). NEO has higher revenues than TWST: NEO (689M) vs TWST (362M).
NEOTWSTNEO / TWST
Capitalization1.03B1.56B66%
EBITDA-28.47M-149.1M19%
Gain YTD-51.578-44.566116%
P/E RatioN/AN/A-
Revenue689M362M190%
Total Cash164M251M65%
Total Debt412M78.2M527%
FUNDAMENTALS RATINGS
NEO vs TWST: Fundamental Ratings
NEO
TWST
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
64
Fair valued
39
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9596
PRICE GROWTH RATING
1..100
4785
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TWST's Valuation (39) in the Biotechnology industry is in the same range as NEO (64) in the Medical Or Nursing Services industry. This means that TWST’s stock grew similarly to NEO’s over the last 12 months.

TWST's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as NEO (100) in the Medical Or Nursing Services industry. This means that TWST’s stock grew similarly to NEO’s over the last 12 months.

NEO's SMR Rating (95) in the Medical Or Nursing Services industry is in the same range as TWST (96) in the Biotechnology industry. This means that NEO’s stock grew similarly to TWST’s over the last 12 months.

NEO's Price Growth Rating (47) in the Medical Or Nursing Services industry is somewhat better than the same rating for TWST (85) in the Biotechnology industry. This means that NEO’s stock grew somewhat faster than TWST’s over the last 12 months.

NEO's P/E Growth Rating (100) in the Medical Or Nursing Services industry is in the same range as TWST (100) in the Biotechnology industry. This means that NEO’s stock grew similarly to TWST’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
NEOTWST
RSI
ODDS (%)
Bearish Trend 4 days ago
71%
Bullish Trend 4 days ago
77%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
79%
Bullish Trend 4 days ago
81%
Momentum
ODDS (%)
Bullish Trend 4 days ago
73%
Bearish Trend 4 days ago
90%
MACD
ODDS (%)
Bullish Trend 4 days ago
71%
Bullish Trend 4 days ago
78%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
77%
Bearish Trend 4 days ago
88%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
76%
Bearish Trend 4 days ago
87%
Advances
ODDS (%)
Bullish Trend 7 days ago
78%
Bullish Trend 18 days ago
78%
Declines
ODDS (%)
Bearish Trend 4 days ago
83%
Bearish Trend 5 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
73%
Bullish Trend 5 days ago
76%
Aroon
ODDS (%)
Bullish Trend 4 days ago
83%
Bearish Trend 4 days ago
87%
View a ticker or compare two or three
Interact to see
Advertisement
NEO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TWST
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MSJCX19.050.50
+2.70%
Morgan Stanley Global Endurance C
TSRMX16.630.16
+0.97%
Touchstone Sands Cptl Emerg Mkts Gr R6
JNBAX10.340.04
+0.39%
JPMorgan Income Builder A
SDVSX17.33-0.02
-0.12%
Sit Dividend Growth S
FAFSX38.14-0.56
-1.45%
Fidelity Advisor Financials M

NEO and

Correlation & Price change

A.I.dvisor indicates that over the last year, NEO has been loosely correlated with RGEN. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if NEO jumps, then RGEN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NEO
1D Price
Change %
NEO100%
-0.99%
RGEN - NEO
38%
Loosely correlated
+3.30%
FLGT - NEO
37%
Loosely correlated
-0.14%
VCYT - NEO
36%
Loosely correlated
+2.89%
NNOX - NEO
36%
Loosely correlated
-0.81%
TWST - NEO
35%
Loosely correlated
+0.51%
More

TWST and

Correlation & Price change

A.I.dvisor indicates that over the last year, TWST has been loosely correlated with VCYT. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if TWST jumps, then VCYT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TWST
1D Price
Change %
TWST100%
+0.51%
VCYT - TWST
51%
Loosely correlated
+2.89%
ITGR - TWST
50%
Loosely correlated
+0.32%
ILMN - TWST
50%
Loosely correlated
+1.28%
A - TWST
49%
Loosely correlated
+0.21%
BLFS - TWST
49%
Loosely correlated
+2.28%
More